Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingMay 14, 2025TESTOSTERONE PELLET 200 mg BLUNTPresence of Particulate Matter: Glass particles were found in pellet vials.Bso LLC · D-0416-2025Class IIOngoingMay 14, 2025TESTOSTERONE PELLET 200 mgPresence of Particulate Matter: Glass particles were found in pellet vials.Bso LLC · D-0415-2025Class IIOngoingMay 14, 2025TESTOSTERONE PELLET 200 mg BLUNTPresence of Particulate Matter: Glass particles were found in pellet vials.Bso LLC · D-0414-2025Class IIOngoingMay 14, 2025TESTOSTERONE PELLET 200 mgPresence of Particulate Matter: Glass particles were found in pellet vials.Bso LLC · D-0413-2025Class IIOngoingMay 14, 2025TESTOSTERONE PELLET 100 mgPresence of Particulate Matter: Glass particles were found in pellet vials.Bso LLC · D-0412-2025Class IIOngoingMay 14, 2025Clindamycin HCl CapsuleCGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.RemedyRePack Inc. · D-0411-2025Class IIOngoingMay 14, 2025temper tamerCGMP DeviationsSiddha Flower Essences, LLC. · D-0410-2025Class IIOngoingMay 14, 2025FentaNYL 500mcgLack of Assurance of SterilityApollo Care, LLC · D-0409-2025Class IIOngoingMay 14, 2025Polyvinyl Alcohol Ophthalmic Solution 1.4%cGMP deviations and lack of assurance of sterility.BRS Analytical Services, LLC · D-0408-2025Class IIOngoingMay 14, 2025Lubricant Eye Drops SolutioncGMP deviations and lack of assurance of sterility.BRS Analytical Services, LLC · D-0407-2025Class IIOngoingMay 14, 2025Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%cGMP deviations and lack of assurance of sterility.BRS Analytical Services, LLC · D-0406-2025Class IIOngoingMay 14, 2025Carboxymethylcellulose Sodium Ophthalmic Gel 1%cGMP deviations and lack of assurance of sterility.BRS Analytical Services, LLC · D-0405-2025Class IIOngoingMay 14, 2025Artificial Tears Ophthalmic SolutioncGMP deviations and lack of assurance of sterility.BRS Analytical Services, LLC · D-0404-2025Class IIOngoingMay 14, 2025Timolol Maleate Ophthalmic Solution USPDefective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.FDC Limited · D-0403-2025Class ITerminatedMay 14, 2025Ropivacaine Hydrochloride InjectionPresence of Particulate MatterAmneal Pharmaceuticals, LLC · D-0402-2025Class IIOngoingMay 7, 2025Infuvite AdultSevere thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on...Mckesson Medical-Surgical Inc. Corporate Office · D-0401-2025Class IIOngoingMay 7, 2025Medroxyprogesterone Acetate Injectable SuspensionSevere thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on...Mckesson Medical-Surgical Inc. Corporate Office · D-0400-2025Class IIOngoingMay 7, 2025niCARdipine Hydrochloride InjectionLack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.American Regent, Inc. · D-0399-2025Class IIOngoingMay 7, 2025niCARdipine Hydrochloride InjectionLack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.American Regent, Inc. · D-0398-2025Class IIOngoingMay 7, 2025Levothyroxine Sodium TabletsSubpotentAccord Healthcare, Inc. · D-0397-2025Class IIOngoingMay 7, 2025Levothyroxine Sodium TabletsSubpotentAccord Healthcare, Inc. · D-0396-2025Class IIOngoingMay 7, 2025Levothyroxine Sodium TabletsSubpotentAccord Healthcare, Inc. · D-0395-2025Class IIOngoingMay 7, 2025Levothyroxine Sodium TabletsSubpotentAccord Healthcare, Inc. · D-0394-2025Class IIOngoingMay 7, 2025Wegovy (semaglutide) injectionTemperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal...Cardinal Health Inc. · D-0393-2025Class IIOngoingMay 7, 2025Dexonto 0.4%Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on...Nubratori, Inc · D-0392-2025Class IIOngoingMay 7, 2025Clindamycin Hydrochloride CapsulescGMP DeviationsPreferred Pharmaceuticals, Inc. · D-0391-2025Class IIOngoingMay 7, 2025Tirofiban Hydrochloride Injection 12.5 mg/250 mLOut-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.Eugia US LLC · D-0390-2025Class IIOngoingMay 7, 2025Tirofiban Hydrochloride Injection 5 mg/100 mLOut-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.Eugia US LLC · D-0389-2025Class IIOngoingApr 30, 2025Duloxetine Delayed-Release Capsules USPCGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.Breckenridge Pharmaceutical, Inc · D-0388-2025Class IIOngoingApr 30, 2025Duloxetine Delayed-Release Capsules USPCGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.Breckenridge Pharmaceutical, Inc · D-0387-2025Class IITerminatedApr 30, 2025Bimatoprost powderCGMP DeviationsMedisca Inc. · D-0386-2025Class IIITerminatedApr 30, 2025HYDROmorphone Hydrochloride 50mg/50mLSuperpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..OurPharma LLC · D-0385-2025Class IITerminatedApr 30, 2025Urodel, Urinary Tract Infection Symptoms ReliefcGMP deviationsPharmadel, LLC · D-0384-2025Class IITerminatedApr 30, 2025Rapidol Arnica TabletscGMP deviationsPharmadel, LLC · D-0383-2025Class IITerminatedApr 30, 2025Rapidol Arnica GelcGMP deviationsPharmadel, LLC · D-0382-2025Class IITerminatedApr 30, 2025KingskincGMP deviationsPharmadel, LLC · D-0381-2025Class IITerminatedApr 30, 2025DoloEar Earache DropscGMP deviationsPharmadel, LLC · D-0380-2025Class IITerminatedApr 30, 2025DoloDent Maximum Strength Toothache DropscGMP deviationsPharmadel, LLC · D-0379-2025Class IIOngoingApr 30, 2025Clindamycin HClCGMP DeviationsRemedyRepack Inc. · D-0378-2025Class IITerminatedApr 30, 2025clomiPRAMINE hydrochloride Capsules USPFailed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month...Lupin Pharmaceuticals Inc. · D-0377-2025